Atul Ltd 2019-20

Corporate Overview Statutory Reports Financial Statements 01-21 22-91 92-228 128 Atul Ltd | Annual Report 2019-20 ( ` cr) Note 21 Revenue from operations 2019-20 2018-19 Sale of products 3,767.14 3,800.11 Sale of services 1 56.54 45.13 Scrap sales 9.04 8.74 Processing charges 8.30 8.06 Revenue from contracts with customers 3,841.02 3,862.04 Export incentives 64.64 53.77 3,905.66 3,915.81 1 Includes ` 53.19 cr (2018-19: ` 42.86 cr) on account of freight and insurance in sale of goods on CIF (Cost, Insurance and Freight ) which are identified as separate performance obligation under Ind AS 115. Disaggregation of revenue from contracts with customers: ( ` cr) Particulars 2019-20 2018-19 Sale of goods | services Life Science Chemicals 1,177.07 1,291.42 Domestic 629.48 567.35 Export 547.59 724.07 Performance and Other Chemicals 2,836.15 2,789.99 Domestic 1,544.80 1,605.86 Export 1,291.35 1,184.13 Others 8.02 7.80 4,021.24 4,089.21 Inter-segment revenue 180.22 227.17 3,841.02 3,862.04 Reconciliation of revenue from contracts with customers recognised at contract price: ( ` cr) Particulars 2019-20 2018-19 Contract price 3,888.21 3,886.05 Adjustments for: Consideration payable to customers - discounts 1 (49.58) (22.58) Contract price allocated to unsatisfied performance obligation for sale of services (net ) 2 2.39 (1.43) Revenue from contract with customers 3,841.02 3,862.04 1 Consideration payable to customers like discounts and price reductions offered to customers are estimated on specific identified basis and reduced from the contract price when the Company recognises revenue from the transfer of the related goods or services to the customer and the entity pays or promises to pay the consideration. 2 Unsatisfied performance obligation for sale of services comprises revenue from insurance and freight services for exports in-progress as at March 31, 2020 of ` 3.73 cr, net of revenue recognised for such services for similar contracts in-progress as at March 31, 2019 for ` 6.12 cr. The revenue for exports in progress as at March 31, 2020 will be recognised in 2020-21 upon completion of the exports. The Company has evaluated the impact of COVID-19 resulting from i) the possible constraints to continue its operations and revisions in costs to fulfill the pending obligations, ii) onerous obligations, iii) penalties, if any, relating to breaches of agreements and iv) termination or deferment of contracts by customers. It has concluded that the impact of COVID-19 is not material based on the aforesaid evaluation. Due to the nature of the pandemic, it will continue to monitor developments to identify significant uncertainties relating to revenue in future periods.